Chronic Widespread Pain and White Blood Cell Activation
Proof of Concept Trial to Test the Efficacy of Treatment With Ketotifen on Pain Sensitivity and Association Between Level of Activity and Reactivity of White Blood Cells and Pain Sensitivity in Teenagers With Chronic Widespread Pain
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
This PHASE3 trial investigates Widespread Chronic Pain and is currently completed. McGill University Health Centre/Research Institute of the McGill University Health Centre leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Unknown Status → Completed · Phase: PHASE1_PHASE2 → PHASE3
-
Oct 2019 — Mar 2020 [monthly]
Unknown Status PHASE1_PHASE2
▶ Show 2 earlier versions
-
Jan 2019 — Oct 2019 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2017 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- The Louise And Alan Edwards Foundation
For direct contact, visit the study record on ClinicalTrials.gov .